Core Scientific, Inc./tx
CORZZ· Nasdaq
CORZZCore Scientific, Inc./tx
Filed Feb 27, 2025 · 10-K · 58 days after period end · 0001628280-25-008302
| Metric | Q4 2024 | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | $94.93M | $141.93M | $121.25M | $301.80M |
| Net Income | -$291.15M | -$195.69M | -$434.85M | $60.51M |
| EPS Diluted | -$0.69 | — |
Core Scientific, Inc./tx · CIK 1839341 · Engraved from SEC EDGAR
| — |
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2024 · filed Feb 27, 2025 · 58 d after period end
